Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidylprolyl isomerase A pseudogene 84 (PPIAP84) is a genetic element related to the peptidylprolyl isomerase A (PPIA) gene, which encodes the enzyme cyclophilin A. PPIAP84 is categorized as a pseudogene, indicating that it does not produce a functional protein and lacks direct biological roles or therapeutic relevance[2]. Pseudogenes sometimes participate in gene regulatory networks, such as acting as competing endogenous RNAs, but there is no substantive evidence that PPIAP84 plays such a role; most information regards its annotated existence in gene databases. In contrast, its functional homolog PPIA is widely studied in the context of cancer, inflammation, immune response, and as a cyclosporine-binding protein[1][5][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 84 (PPIAP84).